Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001584759-25-000004
Filing Date
2025-10-03
Accepted
2025-10-03 19:18:01
Documents
1
Period of Report
2025-10-03

Document Format Files

Seq Description Document Type Size
1 form4-10032025_111055.html 4  
1 form4-10032025_111055.xml 4 12006
  Complete submission text file 0001584759-25-000004.txt   13443
Mailing Address 264 TORREY PINES TERRACE DEL MAR CA 92014
Business Address
Heyman Richard A. (Reporting) CIK: 0001584759 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39269 | Film No.: 251375374

Mailing Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 388-5600
Oric Pharmaceuticals, Inc. (Issuer) CIK: 0001796280 (see all company filings)

EIN.: 471787157 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)